Analyzing Waystar (NASDAQ:WAY) and DIAGNOS (OTCMKTS:DGNOF)

DIAGNOS (OTCMKTS:DGNOF) and Waystar (NASDAQ:WAY) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, risk, analyst recommendations, earnings and institutional ownership.

Analyst Recommendations

This is a summary of recent recommendations and price targets for DIAGNOS and Waystar, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DIAGNOS	0	0	0	0	0.00
Waystar	1	2	18	3	2.96

Waystar has a consensus target price of $35.23, indicating a potential upside of 45.39%. Given Waystar’s stronger consensus rating and higher probable upside, analysts plainly believe Waystar is more favorable than DIAGNOS.

Volatility & Risk

DIAGNOS has a beta of -0.1, indicating that its share price is 110% less volatile than the S&P 500. Comparatively, Waystar has a beta of 0.06, indicating that its share price is 94% less volatile than the S&P 500.

Profitability

This table compares DIAGNOS and Waystar’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
DIAGNOS	-7,014.89%	N/A	-192.10%
Waystar	11.18%	7.03%	4.75%

Earnings & Valuation

This table compares DIAGNOS and Waystar”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DIAGNOS	$50,000.00	568.40	-$3.30 million	($0.04)	-5.87
Waystar	$1.10 billion	4.23	$112.09 million	$0.70	34.61

Waystar has higher revenue and earnings than DIAGNOS. DIAGNOS is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks.

Summary

Waystar beats DIAGNOS on 12 of the 13 factors compared between the two stocks.

About DIAGNOS

DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.

About Waystar

Waystar Holding Corp. is a software company which provide healthcare payments. Waystar Holding Corp. is based in LEHI, Utah.